Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>

Macrolides inhibit biofilm formation in several Gram-negative, intrinsically-resistant bacterial species. However, the effect of macrolides upon biofilm formation by susceptible Gram-positive bacteria has been much less explored as such concentrations also inhibit cell growth. To circumvent this pro...

Full description

Bibliographic Details
Main Author: Carlos F. Amábile-Cuevas
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/12/2/187
_version_ 1797622795103895552
author Carlos F. Amábile-Cuevas
author_facet Carlos F. Amábile-Cuevas
author_sort Carlos F. Amábile-Cuevas
collection DOAJ
description Macrolides inhibit biofilm formation in several Gram-negative, intrinsically-resistant bacterial species. However, the effect of macrolides upon biofilm formation by susceptible Gram-positive bacteria has been much less explored as such concentrations also inhibit cell growth. To circumvent this problem, the effect of macrolides (erythromycin, clarithromycin and azithromycin) at 0.5–2 µg/mL, upon biofilm formation, was explored on macrolide-resistant <i>Staphylococcus aureus</i> isolates, using the crystal violet assay with 96-well plates. Early (4 h) biofilm formation by strains having constitutive target-modification resistance was consistently induced by all macrolides but not in azithromycin-treated cells in longer (8 and 12 h) incubation. In inducible-resistance isolates, early biofilm formation was enhanced by some macrolide treatments, compared to similar cell growth in the absence of antibiotics; but the typical decay of biofilms at longer incubation appeared prematurely in macrolide-treated cultures. Biofilm formation in an efflux-mediated resistant isolate was not affected by macrolides. These results indicate that macrolides induce the formation of biofilm by resistant <i>S. aureus</i> isolates, especially during the early stages. This suggests that the empirical use of macrolides against infections caused by resistant <i>S. aureus</i> strains could not only result in clinical failure but even in the enhancement of biofilms, making further treatment difficult.
first_indexed 2024-03-11T09:16:20Z
format Article
id doaj.art-c96ad676c78144dfb799e9793100fc3b
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-11T09:16:20Z
publishDate 2023-01-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-c96ad676c78144dfb799e9793100fc3b2023-11-16T18:41:26ZengMDPI AGAntibiotics2079-63822023-01-0112218710.3390/antibiotics12020187Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>Carlos F. Amábile-Cuevas0Fundacion Lusara, Mexico City 08810, MexicoMacrolides inhibit biofilm formation in several Gram-negative, intrinsically-resistant bacterial species. However, the effect of macrolides upon biofilm formation by susceptible Gram-positive bacteria has been much less explored as such concentrations also inhibit cell growth. To circumvent this problem, the effect of macrolides (erythromycin, clarithromycin and azithromycin) at 0.5–2 µg/mL, upon biofilm formation, was explored on macrolide-resistant <i>Staphylococcus aureus</i> isolates, using the crystal violet assay with 96-well plates. Early (4 h) biofilm formation by strains having constitutive target-modification resistance was consistently induced by all macrolides but not in azithromycin-treated cells in longer (8 and 12 h) incubation. In inducible-resistance isolates, early biofilm formation was enhanced by some macrolide treatments, compared to similar cell growth in the absence of antibiotics; but the typical decay of biofilms at longer incubation appeared prematurely in macrolide-treated cultures. Biofilm formation in an efflux-mediated resistant isolate was not affected by macrolides. These results indicate that macrolides induce the formation of biofilm by resistant <i>S. aureus</i> isolates, especially during the early stages. This suggests that the empirical use of macrolides against infections caused by resistant <i>S. aureus</i> strains could not only result in clinical failure but even in the enhancement of biofilms, making further treatment difficult.https://www.mdpi.com/2079-6382/12/2/187Biofilm<i>S. aureus</i>macrolideserythromycinclarithromycinazithromycin
spellingShingle Carlos F. Amábile-Cuevas
Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>
Antibiotics
Biofilm
<i>S. aureus</i>
macrolides
erythromycin
clarithromycin
azithromycin
title Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>
title_full Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>
title_fullStr Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>
title_full_unstemmed Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>
title_short Macrolides at Clinically-Relevant Concentrations May Induce Biofilm Formation in Macrolide-Resistant <i>Staphylococcus aureus</i>
title_sort macrolides at clinically relevant concentrations may induce biofilm formation in macrolide resistant i staphylococcus aureus i
topic Biofilm
<i>S. aureus</i>
macrolides
erythromycin
clarithromycin
azithromycin
url https://www.mdpi.com/2079-6382/12/2/187
work_keys_str_mv AT carlosfamabilecuevas macrolidesatclinicallyrelevantconcentrationsmayinducebiofilmformationinmacrolideresistantistaphylococcusaureusi